Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 14, 2017; 23(2): 275-285
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.275
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.275
Table 3 Comparison of signal intensity between grades and European Neuroendocrine Society tumor-nodes-metastases stages
| Feature | Grade | ENETS TNM stage1 | ||||||
| Total | G12 | G2-32 | P value | Total | I/II2 | III/IV2 | P value | |
| T1w | 0.395 | 0.659 | ||||||
| Hypointense | 45 | 27 (60) | 18 (40) | 42 | 22 (52.4) | 20 (47.6) | ||
| Isointense | 4 | 1 (25) | 3 (75) | 4 | 1 (25) | 3 (75) | ||
| Hyperintense | 6 | 3 (50) | 3 (50) | 5 | 2 (40) | 3 (60) | ||
| fsT1w | 0.836 | 0.900 | ||||||
| Hypointense | 39 | 23 (59) | 16 (41) | 37 | 19 (51.4) | 18 (48.6) | ||
| Isointense | 9 | 5 (55.6) | 4 (44.4) | 8 | 3 (37.5) | 5 (62.5) | ||
| Hyperintense | 7 | 3 (42.9) | 4 (57.1) | 6 | 3 (50) | 3 (50) | ||
| T2w | 0.937 | 0.274 | ||||||
| Hypointense | 16 | 9 (56.3) | 7 (43.2) | 16 | 8 (50) | 8 (50) | ||
| Isointense | 12 | 6 (50) | 6 (50) | 11 | 3 (27.3) | 8 (72.7) | ||
| Hyperintense | 27 | 16 (59.3) | 11 (40.7) | 24 | 14 (58.3) | 10 (41.7) | ||
| fsT2w | 1.000 | 0.318 | ||||||
| Hypointense | 13 | 7 (53.8) | 6 (46.2) | 13 | 5 (38.5) | 8 (61.5) | ||
| Isointense | 11 | 6 (54.5) | 5 (45.5) | 9 | 3 (33.3) | 6 (66.7) | ||
| Hyperintense | 31 | 18 (58.1) | 13 (41.9) | 29 | 17 (58.6) | 12 (41.4) | ||
| Fluid areas | 0.279 | 0.464 | ||||||
| Present | 15 | 7 (46.7) | 8 (53.3) | 15 | 8 (53.3) | 7 (46.7) | ||
| Absent | 40 | 24 (60) | 16 (40) | 38 | 17 (47.2) | 19 (52.8) | ||
| Arterial | 0.089 | 0.055 | ||||||
| Hypointense | 13 | 4 (30.8) | 9 (69.2) | 12 | 3 (25) | 9 (75) | ||
| Isointense | 11 | 8 (72.7) | 3 (27.3) | 9 | 3 (33.3) | 6 (66.7) | ||
| Hyperintense | 31 | 19 (61.3) | 12 (38.7) | 30 | 19 (63.3) | 11 (36.7) | ||
| Portal | 1.000 | 0.933 | ||||||
| Hypointense | 14 | 8 (57.1) | 6 (42.9) | 14 | 6 (42.9) | 8 (57.1) | ||
| Isointense | 13 | 7 (53.8) | 6 (46.2) | 12 | 6 (50) | 6 (50) | ||
| Hyperintense | 28 | 16 (57.1) | 12 (42.9) | 25 | 13 (52) | 12 (48) | ||
| Delayed | 0.441 | 0.340 | ||||||
| Hypointense | 12 | 6 (50) | 6 (50) | 11 | 4 (36.4) | 7 (63.6) | ||
| Isointense | 19 | 9 (47.4) | 10 (52.6) | 17 | 7 (41.2) | 10 (58.8) | ||
| Hyperintense | 24 | 16 (66.7) | 8 (33.3) | 23 | 14 (60.9) | 9 (39.1) | ||
| Enhancement | 0.006 | 0.163 | ||||||
| Heterogeneous | 25 | 9 (36) | 16 (64) | 25 | 10 (40) | 15 (60) | ||
| Homogeneous | 30 | 22 (73.3) | 8 (26.7) | 26 | 15 (57.7) | 11 (42.3) | ||
- Citation: De Robertis R, Cingarlini S, Tinazzi Martini P, Ortolani S, Butturini G, Landoni L, Regi P, Girelli R, Capelli P, Gobbo S, Tortora G, Scarpa A, Pederzoli P, D’Onofrio M. Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage. World J Gastroenterol 2017; 23(2): 275-285
- URL: https://www.wjgnet.com/1007-9327/full/v23/i2/275.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i2.275